Skip to search formSkip to main contentSkip to account menu

Linomide

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Linomide is a potent immunomodulator that has been shown to inhibit autoimmunity in several animal models of autoimmune disease… 
1999
1999
Since prostate cancer (PC) development involves a combination of genetic predisposition and promotional mechanisms, especially… 
1999
1999
Linomide (quinoline‐3‐carboxamide) is a synthetic immunomodulator that suppresses several experimental autoimmune diseases. Here… 
Highly Cited
1997
Highly Cited
1997
Linomide is a p.o. active antiangiogenic agent that has been demonstrated to be effective in suppressing the in vivo growth of… 
Highly Cited
1993
Highly Cited
1993
Linomide (LS‐2616, quinoline‐3‐carboxamide) is a synthetic immunomodulator that stimulates natural killer cell activity and… 
Highly Cited
1993
Highly Cited
1993
Intravenous injections of 50 μ.g Staphylococcus aureus enterotoxin B (SEB) or bacterial lipopolysaccharide (LPS) are lethal… 
Highly Cited
1992
Highly Cited
1992
Immunostimulatory therapy is at present considered after autologous bone marrow transplantation (ABMT) in order to mimic the… 
1989
1989
The effects of the immunomodulatory drug Linomide (LS-2616) have been investigated on two variants of collagen-induced arthritis… 
1989
1989
The effect of the quinoline-3-carboxamide LS-2616 (Linomide), given alone or together with cyclosporine, was studied in the first…